Mice lacking granulocyte colony-stimulating factor (G-CSF) are neutropenic with reduced hematopoietic progenitors in the bone marrow and spleen, whereas those lacking granulocyte-macrophage colony-stimulating factor (GM-CSF) have impaired pulmonary homeostasis and increased splenic hematopoietic progenitors, but unimpaired steady-state hematopoiesis. These contrasting phenotypes establish unique roles for these factors in vivo, but do not exclude the existence of additional redundant functions. To investigate this issue, we generated animals lacking both G-CSF and GM-CSF. In the process of characterizing the phenotype of these animals, we further analyzed G-CSF– and GM-CSF–deficient mice, expanding the recognized spectrum of defects in both. G-CSF–deficient animals have a marked predisposition to spontaneous infections, a reduced long-term survival, and a high incidence of reactive type AA amyloidosis. GM-CSF–deficient mice have a modest impairment of reproductive capacity, a propensity to develop lung and soft-tissue infections, and a similarly reduced survival as in G-CSF–deficient animals. The phenotype of mice lacking both G-CSF and GM-CSF was additive to the features of the constituent genotypes, with three novel additional features: a greater degree of neutropenia among newborn mice than in those lacking G-CSF alone, an increased neonatal mortality rate, and a dominant influence of the lack of G-CSF on splenic hematopoiesis resulting in significantly reduced numbers of splenic progenitors. In contrast to newborn animals, adult mice lacking both G-CSF and GM-CSF exhibited similar neutrophil levels as G-CSF–deficient animals. These findings demonstrate that the additional lack of GM-CSF in G-CSF–deficient animals further impairs steady-state granulopoiesis in vivo selectively during the early postnatal period, expand the recognized roles of both G-CSF and GM-CSF in vivo, and emphasize the utility of studying multiply deficient mouse strains in the investigation of functional redundancy.

THE BIOLOGIC ACTIVITIES of the hematopoietic growth factors granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) overlap significantly both in vitro1 and following pharmacologic administration in vivo,2,3 raising the possibility of significant functional redundancy of their physiologic roles.4 Initially, this postulated redundancy was explored through the creation of mice lacking either G-CSF5 or GM-CSF.6,7 G-CSF–deficient mice have reduced hematopoietic progenitors in the bone marrow and spleen and neutropenia.5 Despite the potent hematopoietic capacity of GM-CSF, mice lacking this factor manifest no detectable deficiency in steady-state hematopoiesis, but have increased splenic hematopoietic progenitors and an impaired pulmonary surfactant clearance resulting in abnormalities resembling human alveolar proteinosis.6-8 These contrasting phenotypes establish that at least one of the in vivo roles of each factor is unique and indispensable, but do not exclude the existence of additional redundant functions. For instance, the residual granulopoiesis in G-CSF–deficient mice may be a result of the actions of GM-CSF. Furthermore, the normal neutrophil level in GM-CSF–deficient mice does not establish that GM-CSF has no physiologic role in steady-state granulopoiesis, but indicates that in the presence of regulators such as G-CSF any such role is dispensable. A definitive means to explore these issues in vivo is to generate mice simultaneously lacking both factors. In such mice, observation of a novel defect or exacerbation of the phenotypic features of singly deficient animals would unequivocally establish partial in vivo redundancy.9 

We therefore generated mice lacking both G-CSF and GM-CSF. These mice have features consistent with the superimposition of the previously reported and newly recognized abnormalities of the two constituent genotypes; moreover, mice lacking both G-CSF and GM-CSF are more severely neutropenic up to 2 weeks of age than those lacking G-CSF alone, indicating that GM-CSF is physiologically available to support granulopoiesis in the early postnatal period.

Mice.The G-CSF locus is designated “G,” and the GM-CSF locus “GM.” At each of these loci, homozygous wild-type, heterozygous, and homozygous null mice are designated “+/+,” “+/−,” and “−/−,” respectively. For the sake of brevity, where an animal is homozygous wild-type at a given locus, the genotype of the animal at that locus is not specifically stated unless it creates potential ambiguity.

The G−/− and GM−/− mice used were previously described,5,6 and were generated from 129/OLA-derived embryonic stem cells and C57BL/6-derived blastocysts. Similarly outbred 129/OLA × C57BL/6 G+/+GM+/+ mice were used as controls. G+/−GM+/− mice were generated by interbreeding G−/−GM+/+ and G+/+GM−/− strains. Doubly heterozygous progeny were identified by polymerase chain reaction (PCR) screening and interbred to yield G−/−GM−/− animals, which were then mated. PCR genotyping at the G and GM loci was performed on tail DNA of 21-day-old mice as previously described.5 6 All G−/−GM−/− mice studied were progeny of G−/−GM−/− × G−/−GM−/− matings. Mice were housed in a conventional facility unless stated otherwise, fed food pellets and water ad libitum, and killed if distressed. Experimentation followed the guidelines of the Animal Welfare Committee of the National Health and Medical Research Council and was approved by the institutional Animal Ethics Committee.

Hematologic analysis.In mice aged at least 14 days, retro-orbital venous plexus blood was sampled using EDTA-coated microhematocrit tubes (Clay Adams, Parsippany, NJ), diluted immediately 1:4 in 2 mg/mL EDTA in mouse-tonicity phosphate-buffered saline, and analyzed using a Sysmex-K1000 automated counter (Toa Medical Electronics Co, Kobe, Japan). Peripheral blood smears were stained with May-Grünwald/Giemsa, and manual differential cell counts of at least 200 nucleated cells were performed. Absolute neutrophil levels were then calculated using the total leukocyte count after appropriate correction for nucleated red blood cells where present. Before 14 days of age, jugular venous blood was collected as previously described10 and diluted between 1:5 and 1:7.5. Differential analyses of May-Grünwald/Giemsa–stained cytospin smears of spleen and peritoneal-wash cell suspensions were based on manual counts of 100 to 200 cells. Bone marrow differential analyses were based on the mean of two manual counts of 500 cells from duplicate smears. All differential analyses were performed by a single investigator. Only apparently healthy animals were sampled for these studies.

Progenitor assays.In vitro hematopoietic colony-forming cells were enumerated in triplicate semisolid agar cultures as described previously.11 Colony formation was stimulated with pokeweed mitogen–stimulated spleen-conditioned medium ([SCM] 10% vol/vol) or the following purified bacterially synthesized recombinant proteins singly or in combination: human G-CSF 10 ng/mL (Amgen, Melbourne, Australia), murine GM-CSF 10 ng/mL (Dr N. Nicola, Cooperative Research Centre for Cellular Growth Factors, Parkville, Australia), and pegylated rat stem cell factor (SCF) 100 ng/mL (Amgen, Thousand Oaks, CA). Cultures were incubated for 7 days at 37°C in a fully humidified atmosphere of 5% CO2 in air. Colonies were defined as clones containing at least 50 cells, except for megakaryocytic colonies, which were defined as clones containing at least three megakaryocytes, and were counted using a dissecting microscope at 35-fold magnification. To classify colonies, whole plates were fixed in 2.5% glutaraldehyde in normal saline, dried, stained sequentially with acetylcholinesterase, Luxol Fast Blue, and hematoxylin, mounted, and examined at 200- to 400-fold magnification.

Histologic analysis.The histologic survey of 8- to 12-week-old G−/−GM−/− animals examined 10% buffered Formalin-fixed, paraffin-embedded sections of lung, heart, thymus, lymph node, liver, kidney, pancreas, stomach, small and large intestine, spleen, bone marrow, bone shaft, brain, and eye stained with hematoxylin and eosin. For some analyses, lungs were harvested en bloc and inflated with 1 mL 10% buffered Formalin following tracheal cannulation.

Pulmonary pathologic changes were scored using a histologic grading scale incorporating both the severity and extent of abnormalities. The severity of alveolar surfactant deposition and pulmonary lymphoid accumulation were scored separately on a qualitative scale from 1 to 4. For scoring surfactant deposition, affected areas were graded as follows: grade 1, sparse focal granular deposits within a minority of alveoli; grade 2, more uniform and extensive granular deposits within the majority of alveoli; grade 3, extensive granular deposits, becoming confluent in some alveoli; and grade 4, uniformly confluent deposits appearing to completely fill affected alveoli. In the lungs of healthy wild-type mice, there were occasionally small perivascular clusters of small mature lymphocytes. Pulmonary lymphoid accumulation was scored as grade 1 if there were lymphocytic foci slightly larger than usually seen in normal mice but less than 10 cells thick in section; grade 2, segmental lymphoid foci of greater than 10-cell thickness in section, or narrow circumferential accumulations surrounding some vessels; grade 3, more extensive circumferential lesions, which may completely bridge the areas between adjacent vessels or bronchi; and grade 4, extensive areas of lymphoid accumulation no longer confined to the perivascular or peribronchial zones, but extending interstitially into surrounding lung parenchyma. These grading schema had good intraobserver reproducibility, with at least 80% of specimens scored identically for both proteinosis and lymphoid accumulation on repeated analyses with a maximum discrepancy of one grade between analyses (n = 44). Visual estimations of the percentage of both vascular involvement by lymphoid aggregates and lung fields affected by abnormal surfactant accumulation were also reproducible, each with a mean difference of less than 15% on repeated analyses.

Congo red staining and analysis of the potassium permanganate sensitivity of Congo red staining were performed as previously described,12,13 and were examined under crossed polarizing filters (Nikon, Tokyo, Japan). To be considered positive for amyloid, tissues were required to stain positively with Congo red and to demonstrate green birefringence under crossed polarizing filters. The severity of amyloidosis was graded from 1 (slight) to 3 (extensive) using the criteria of Janigan.14 

Microbiologic analysis.Tissue samples for microbiologic analysis were obtained immediately following killing, prepared for examination by light-microscopy after Gram staining, and processed for bacterial culture using standard methods.15 Animals found dead were not subject to microbiologic analysis.

Survival analysis.For the survival studies, a cohort of 219 mice were set aside in the conventional animal house environment and prospectively evaluated without intervention. Animals that were clearly distressed were killed. A group of 32 apparently healthy mice were culled in error at 34 to 44 weeks of age, and were censored at the time of culling. All other animals were evaluated until death or until illness necessitating killing, and those still alive at the most recent analysis were censored at that date.

Statistics.Numeric data are presented as the mean ± 1 SD unless stated otherwise. Comparisons between nominal data were made using Fisher's exact test or the χ2 test and between ordinal data using the Mann-Whitney U test or Kruskal-Wallis test as appropriate. P values less than .05 after appropriate correction for multiple comparisons using the Holm modification of the Bonferroni procedure16 were regarded as significant. Survival data were analyzed using the method of Kaplan and Meier and compared using the log-rank test. Multivariate regression analysis was performed on Winstat 3.0 software (Kalmia Co, Cambridge, MA) using a forward stepwise procedure with incorporation of all independent variables with a univariate P value less than .05.

Viability and fertility of G−/−GM−/− mice.Mendelian inheritance patterns predict that an average of one in 16 offspring (6.25%) from G+/−GM+/− × G+/−GM+/− matings should be of the doubly nullizygous genotype (G−/−GM−/−). Of 342 pups born to such matings surviving to weaning and hence to genotyping, only nine (2.6%; 95% confidence interval, 1.2% to 4.9%) were confirmed to be G−/−GM−/−. This frequency is lower than predicted, confirming selective loss of G−/−GM−/− animals. These data do not separate the relative contribution of prenatal and postnatal loss of pups. However, the increased neonatal mortality rate among viable G−/−GM−/− pups born to doubly nullizygous mothers (Table 1) appears insufficient to completely account for the skewed distribution of genotypes among successfully weaned animals. This suggests that there may additionally be a selective loss of G−/−GM−/− embryos.

Table 1.

Litter Size and Neonatal Survival

ParameterGenotype
Wild-TypeG−/−GM−/−G−/−GM−/−
No. of mating pairs active 29 20 10 
Total no. of litters born 96 25 45 25 
No. of pups born per litter (mean ± SD) 8.6 ± 3.0 8.0 ± 2.9 7.3 ± 3.5* 7.0 ± 2.5* 
No. of pups weaned per litter (mean ± SD) 6.5 ± 3.9 7.0 ± 3.0 5.6 ± 3.3 4.3 ± 3.3* 
Crude neonatal mortality rate (%) 24 12* 23 39* 
Percentage of male pups at weaning (mean ± SD) 49 ± 20 43 ± 17 55 ± 23 43 ± 22 
ParameterGenotype
Wild-TypeG−/−GM−/−G−/−GM−/−
No. of mating pairs active 29 20 10 
Total no. of litters born 96 25 45 25 
No. of pups born per litter (mean ± SD) 8.6 ± 3.0 8.0 ± 2.9 7.3 ± 3.5* 7.0 ± 2.5* 
No. of pups weaned per litter (mean ± SD) 6.5 ± 3.9 7.0 ± 3.0 5.6 ± 3.3 4.3 ± 3.3* 
Crude neonatal mortality rate (%) 24 12* 23 39* 
Percentage of male pups at weaning (mean ± SD) 49 ± 20 43 ± 17 55 ± 23 43 ± 22 

Data collected for all mating pairs of the given genotypes active over a continuous 6-month period in the same conventional animal house environment. Mating pairs were all crosses between pairs of the genotype shown in the respective column.

*

P < .05 v wild-type.

P < .05 for heterogeneity across all genotypes.

G−/−GM−/− mice appeared healthy, developed normally, and were fertile, but displayed a modest impairment of reproductive capacity and reduced neonatal survival (Table 1). The lack of GM-CSF was the major variable influencing litter size. G−/−GM−/− and G+/+GM−/− mating pairs produced litters of a similar mean size, but both were smaller than wild-type litters. By contrast, there was no reduction in the size of litters born to G−/− matings. The early survival of G−/−GM−/− pups was also significantly impaired. These differences were unrelated to gender. It was not possible to determine the specific cause of these neonatal deaths, as few animals were available for histologic analysis (due to maternal cannibalism). However, the timing of these deaths among G−/−GM−/− pups coincided with a period of marked neutropenia (detailed later), raising the possibility that they were related to infections.

Hematologic analysis of G−/−GM−/− mice.The initial evaluation of hematopoiesis consisted of a comparison of six pairs of 8- to 12-week-old G−/−GM−/− and wild-type mice. While no differences in total femoral cellularity were evident, the cellular composition differed markedly. In G−/−GM−/− mice, both early (myelocytes and promyelocytes, 5.6% ± 1.3%) and late (metamyelocytes and polymorphonuclear forms, 20.0% ± 3.4%) neutrophil precursors were reduced relative to those in wild-type animals (11.4% ± 3.7% and 32.8% ± 4.8%, respectively). The percentage of bone marrow eosinophils was lower in G−/−GM−/− mice, although the absolute difference was small (1.4% ± 1.0% v 2.6% ± 1.0%). The reduction in myeloid precursors in G−/−GM−/− animals was accompanied by a proportional increase in morphologically mature lymphocytes (47.8% ± 5.4% v 30.5% ± 5.1%). The percentage of erythroid and monocytic cells was not disturbed in G−/−GM−/− animals. These alterations in bone marrow cellular composition are similar in nature and degree to those previously described in mice lacking G-CSF alone.5 

There was no difference in body weight, spleen weight, cell yield from peritoneal lavage, or cellular composition of peritoneal lavage or spleen cell suspensions between these 8- to 12-week-old G−/−GM−/− and control animals (data not shown).

Bone marrow hematopoietic progenitors.Consistent with the reduction in morphologically recognizable neutrophil precursors in the bone marrow of G−/−GM−/− animals, the total number of colony-forming cells responsive to all stimuli tested was lower than in control mice, although these differences did not attain statistical significance (Table 2). The most prominent reduction observed among G−/−GM−/− mice was in the number of macrophage colonies formed in response to GM-CSF. In further experiments with a total of eight mice per genotype, no significant differences in the number or type of colonies formed in response to G-CSF either alone or in combination with GM-CSF were found between G−/−GM−/− and control animals (data not shown).

Table 2.

Colony-Forming Cells in the Bone Marrow and Spleen of Wild-Type, G−/−, GM−/−, and G−/−GM−/− Mice

Cell SourceStimulusGenotypeTotalGranulocyteMacrophageGranulocyte/Macrophage
Bone marrow SCM Wild-type 48 ± 5 12 ± 8 12 ± 6 20 ± 3 
  G−/− 31 ± 12 7 ± 2 11 ± 7 10 ± 3* 
  GM−/− 27 ± 14 5 ± 2 10 ± 6 11 ± 6 
  G−/−GM−/− 40 ± 8 9 ± 4 13 ± 6 15 ± 5 
 GM-CSF Wild-type 53 ± 14 13 ± 7 13 ± 5 28 ± 10 
  G−/− 24 ± 5* 6 ± 1 6 ± 1* 12 ± 4* 
  GM−/− 34 ± 15 10 ± 2 8 ± 6 16 ± 10 
  G−/−GM−/− 32 ± 14 10 ± 6 4 ± 3* 17 ± 6 
 SCF Wild-type 25 ± 10 12 ± 7 1 ± 1 10 ± 5 
  G−/− 21 ± 6 11 ± 4 1 ± 1 8 ± 5 
  GM−/− 18 ± 9 9 ± 2 0 ± 0 7 ± 6 
  G−/−GM−/− 19 ± 7 11 ± 3 1 ± 1 6 ± 3 
Spleen SCM Wild-type 16 ± 11 2 ± 2 4 ± 3 7 ± 5 
  G−/− 10 ± 4 1 ± 1 2 ± 1 5 ± 2 
  GM−/− 31 ± 22 3 ± 2 7 ± 8 17 ± 10 
  G−/−GM−/− 8 ± 3 1 ± 0 2 ± 1 4 ± 2 
 GM-CSF Wild-type 12 ± 6 2 ± 2 2 ± 2 8 ± 3 
  G−/− 3 ± 3* 0 ± 0 1 ± 2 2 ± 1* 
  GM−/− 19 ± 12 4 ± 3 1 ± 1 13 ± 8 
  G−/−GM−/− 3 ± 2*† 1 ± 1 0 ± 0*† 2 ± 2*† 
 SCF Wild-type 11 ± 8 5 ± 4 1 ± 1 4 ± 4 
  G−/− 6 ± 3 2 ± 2 1 ± 0 3 ± 2 
  GM−/− 26 ± 21 12 ± 11 2 ± 2 4 ± 4 
  G−/−GM−/− 3 ± 2* 1 ± 1 0 ± 1 1 ± 1*† 
 SCF + GM-CSF Wild-type 28 ± 14 6 ± 3 3 ± 1 18 ± 11 
  G−/− 17 ± 11 2 ± 1* 2 ± 2 13 ± 10 
  GM−/− 62 ± 38 7 ± 5 5 ± 1*‡ 45 ± 31 
  G−/−GM−/− 10 ± 6*† 2 ± 1 2 ± 1 6 ± 4 
Cell SourceStimulusGenotypeTotalGranulocyteMacrophageGranulocyte/Macrophage
Bone marrow SCM Wild-type 48 ± 5 12 ± 8 12 ± 6 20 ± 3 
  G−/− 31 ± 12 7 ± 2 11 ± 7 10 ± 3* 
  GM−/− 27 ± 14 5 ± 2 10 ± 6 11 ± 6 
  G−/−GM−/− 40 ± 8 9 ± 4 13 ± 6 15 ± 5 
 GM-CSF Wild-type 53 ± 14 13 ± 7 13 ± 5 28 ± 10 
  G−/− 24 ± 5* 6 ± 1 6 ± 1* 12 ± 4* 
  GM−/− 34 ± 15 10 ± 2 8 ± 6 16 ± 10 
  G−/−GM−/− 32 ± 14 10 ± 6 4 ± 3* 17 ± 6 
 SCF Wild-type 25 ± 10 12 ± 7 1 ± 1 10 ± 5 
  G−/− 21 ± 6 11 ± 4 1 ± 1 8 ± 5 
  GM−/− 18 ± 9 9 ± 2 0 ± 0 7 ± 6 
  G−/−GM−/− 19 ± 7 11 ± 3 1 ± 1 6 ± 3 
Spleen SCM Wild-type 16 ± 11 2 ± 2 4 ± 3 7 ± 5 
  G−/− 10 ± 4 1 ± 1 2 ± 1 5 ± 2 
  GM−/− 31 ± 22 3 ± 2 7 ± 8 17 ± 10 
  G−/−GM−/− 8 ± 3 1 ± 0 2 ± 1 4 ± 2 
 GM-CSF Wild-type 12 ± 6 2 ± 2 2 ± 2 8 ± 3 
  G−/− 3 ± 3* 0 ± 0 1 ± 2 2 ± 1* 
  GM−/− 19 ± 12 4 ± 3 1 ± 1 13 ± 8 
  G−/−GM−/− 3 ± 2*† 1 ± 1 0 ± 0*† 2 ± 2*† 
 SCF Wild-type 11 ± 8 5 ± 4 1 ± 1 4 ± 4 
  G−/− 6 ± 3 2 ± 2 1 ± 0 3 ± 2 
  GM−/− 26 ± 21 12 ± 11 2 ± 2 4 ± 4 
  G−/−GM−/− 3 ± 2* 1 ± 1 0 ± 1 1 ± 1*† 
 SCF + GM-CSF Wild-type 28 ± 14 6 ± 3 3 ± 1 18 ± 11 
  G−/− 17 ± 11 2 ± 1* 2 ± 2 13 ± 10 
  GM−/− 62 ± 38 7 ± 5 5 ± 1*‡ 45 ± 31 
  G−/−GM−/− 10 ± 6*† 2 ± 1 2 ± 1 6 ± 4 

Four mice were studied per genotype with each cell source and stimulus. All comparisons were made using the Mann-Whitney U test. Results were rounded to the nearest whole number after analysis and are expressed as the mean ± 1 SD number of colony-forming cells of triplicate determinations per 25,000 unselected bone marrow cells and per 200,000 unselected spleen cells. The sum of granulocyte, macrophage, and granulocyte-macrophage colonies may not equal total colonies, as mixed-lineage (megakaryocytic and granulocytic/monocytic or eosinophilic and granulocytic/monocytic), pure blast, and pure megakaryocytic colonies were quantified separately but are not tabulated. The sum of these additional colony types constituted a mean of 5.0% ± 3.8% of total bone marrow colonies and 7.9% ± 5.8% of total spleen colonies, and none of the 3 genotypes studied differed significantly from the wild-type.

*

P < .05 v wild-type.

P < .05 v GM−/−.

P < .05 v G−/−.

Concordant with the initial study of GM−/− mice,6 no significant differences compared with the control mice were noted in the number or type of colonies formed in response to any of the stimuli tested. Also consistent with the initial report,5 G−/− animals in the present study showed a significant reduction in total colony-forming cells responsive to GM-CSF (45% of control), due to the formation of fewer pure macrophage and mixed granulocyte-macrophage colonies, and fewer mixed granulocyte-macrophage colonies formed in response to SCM.

There were no significant differences between G−/− and G−/−GM−/− mice in any of the colony-forming assays performed, demonstrating that the diminution of bone marrow progenitors in G−/−GM−/− mice is solely a consequence of G-CSF deficiency.

Splenic hematopoietic progenitors.The initial description of GM−/− mice noted an increase in the number of progenitors in the spleen.6 Although not statistically significantly greater than in wild-type mice, a similar tendency was evident with all stimuli tested in the current studies (mean total colonies, 201% of wild-type; Table 2). Conversely, G−/− mice had significantly fewer splenic progenitors responsive to GM-CSF than control mice, with a trend toward a similar reduction with the other stimuli tested. These divergent tendencies toward increased splenic progenitors among GM−/− mice and diminished splenic progenitors among both G−/− and G−/−GM−/− animals resulted in significant differences between GM−/− and both G−/− and G−/−GM−/− mice for most comparisons (Table 2).

In G−/−GM−/− mice, there were significant reductions in the total number of colony-forming cells in the spleen in response to GM-CSF, SCF, and the two stimuli combined. All classes of colonies were similarly affected. In additional studies using G-CSF alone or in combination with GM-CSF, the total number of splenic progenitors was also significantly lower in G−/−GM−/− compared with wild-type (data not shown). These findings are consistent with a “dominant” influence of the lack of G-CSF on the hematopoietic status of G−/−GM−/− animals, and suggest that the lack of GM-CSF does not result in any additive effect on the splenic progenitor numbers in G−/− mice, as there were no statistically significant differences observed between G−/− and G−/−GM−/− mice.

Peripheral blood neutrophil levels.Peripheral blood cell counts were studied in cohorts of mice between the ages of 3 days and 12 to 18 months, and are arbitrarily divided into those dealing with mature adult hematopoiesis (8 weeks to 12 to 18 months) and the period from 3 days to 2 weeks of age that we have termed “neonatal” (Fig 1).

Fig. 1.

Peripheral blood absolute neutrophil counts. At age 3 days, 8 to 15 mice per genotype were assayed on 5 separate days; at age 14 days, 6 to 8 mice on 1 day; at age 8 weeks, 8 to 14 mice on 3 days; at age 11 weeks, 8 to 12 mice on 3 days; at age 20 weeks, 14 to 24 mice on 3 days; and at age 30 weeks, 8 to 14 mice on 3 days. The columns labeled 12-18 Mo comprised results from 7 to 9 mice per genotype ranging from 13 to 18 months of age analyzed on 2 separate days. The gender of animals studied at ≤14 days of age could not be determined by external examination, and all older mice studied were male. Results were pooled and are shown as the mean ± 1 SD. All comparisons are between mice of a given age cohort. *P < .05 v wild-type; #P < .05, G−/− v G−/−GM−/−.

Fig. 1.

Peripheral blood absolute neutrophil counts. At age 3 days, 8 to 15 mice per genotype were assayed on 5 separate days; at age 14 days, 6 to 8 mice on 1 day; at age 8 weeks, 8 to 14 mice on 3 days; at age 11 weeks, 8 to 12 mice on 3 days; at age 20 weeks, 14 to 24 mice on 3 days; and at age 30 weeks, 8 to 14 mice on 3 days. The columns labeled 12-18 Mo comprised results from 7 to 9 mice per genotype ranging from 13 to 18 months of age analyzed on 2 separate days. The gender of animals studied at ≤14 days of age could not be determined by external examination, and all older mice studied were male. Results were pooled and are shown as the mean ± 1 SD. All comparisons are between mice of a given age cohort. *P < .05 v wild-type; #P < .05, G−/− v G−/−GM−/−.

Close modal

Adult.No consistent differences in hemoglobin level, red blood cell count, hematocrit, platelet count, and total or differential white blood cell count, including the eosinophil count, were observed between GM−/− and control mice throughout the age range studied (data not shown). The neutropenia of G−/− mice persisted at a relatively constant level throughout adult life (mean absolute neutrophil count, 30% of wild-type). During the adult period, G−/−GM−/− mice were chronically neutropenic to a similar degree as G−/− mice (mean absolute neutrophil count, 24% of wild-type), with no other consistent abnormalities (data not shown). Although the absolute neutrophil count of G−/−GM−/− mice was numerically lower than that of G−/− mice at 8, 11, 20, and 30 weeks of age, none of these differences attained statistical significance. Thus, there is no evidence of further impairment of adult steady-state granulopoiesis due to the additional lack of GM-CSF in G-CSF–deficient mice.

Neonatal.Examination of the peripheral blood of mice up to 14 days of age showed similar trends, but with three novel findings. Unlike the situation in adult mice, young G−/−GM−/− animals were more severely neutropenic than G−/− mice at both 3 and 14 days of age. At 14 days of age, GM−/− mice had significantly greater neutrophil counts than control animals. When expressed relative to wild-type animals of the same age to control for observed changes in neutrophil counts with maturation, young G−/− mice were also relatively less neutropenic than adult G−/− animals (a mean of 58% v 30% of wild-type levels). No other differences between genotypes for any other parameters were noted.

Mice of all four genotypes exhibited the normal dynamic alteration in neutrophil levels during the first 8 weeks of life,10 indicating that neither maternal nor endogenous G-CSF or GM-CSF are essential for these fluctuations.

Colony-stimulating capacity of SCM from G−/−GM−/− mice.SCM prepared from G−/−GM−/− mice was 80% less potent than SCM prepared from control animals; the maximum number of colonies produced was 16 ± 9 versus 81 ± 11 (Fig 2). All classes of myeloid colonies were similarly reduced, although pure granulocytic colonies were still formed in response to G−/−GM−/− SCM despite lacking both G-CSF and GM-CSF.

Fig. 2.

Reduced colony-stimulating capacity of SCM from G−/−GM−/− mice. Pokeweed mitogen–stimulated SCM was prepared from 4 G−/−GM−/− mice and age- and sex-matched wild-type mice using standard methods,11 and assayed for colony-stimulating capacity using G+/+GM+/+ C57BL/6 bone marrow in triplicate semisolid agar cultures with serial 1:2 dilutions of SCM as stimuli. Colonies were scored at 7 days. Results are shown as the mean ± 1 SD for 4 experiments per genotype. At the highest SCM concentration, the mean absolute numbers of pure granulocyte (1.4 v 12.9), pure macrophage (3.2 v 24.4), and mixed granulocyte/macrophage (10.0 v 42.6) colonies formed were all lower with G−/−GM−/− media v wild-type.

Fig. 2.

Reduced colony-stimulating capacity of SCM from G−/−GM−/− mice. Pokeweed mitogen–stimulated SCM was prepared from 4 G−/−GM−/− mice and age- and sex-matched wild-type mice using standard methods,11 and assayed for colony-stimulating capacity using G+/+GM+/+ C57BL/6 bone marrow in triplicate semisolid agar cultures with serial 1:2 dilutions of SCM as stimuli. Colonies were scored at 7 days. Results are shown as the mean ± 1 SD for 4 experiments per genotype. At the highest SCM concentration, the mean absolute numbers of pure granulocyte (1.4 v 12.9), pure macrophage (3.2 v 24.4), and mixed granulocyte/macrophage (10.0 v 42.6) colonies formed were all lower with G−/−GM−/− media v wild-type.

Close modal

Characterization of pulmonary disease in G−/−GM−/− mice.The major histologic abnormalities in eight apparently healthy 8- to 12-week-old G−/−GM−/− mice were confined to the lungs. Although a single 12-week-old male animal had widespread amyloid deposition (discussed later), other organs in these animals had no consistent abnormalities evident.

The lungs contained a variable degree of perivascular lymphoid accumulation, preferentially affecting hilar vessels, and widespread intra-alveolar surfactant accumulation (Fig 3B to D), as described in mice lacking GM-CSF (Fig 3A).6 7 Neither the extent nor the severity of these changes were greater than in an age-matched cohort of GM−/− mice.

Fig. 3.

Illustrative sections of the range of severity of the observed pulmonary pathology. (A) Grade 2 proteinosis: relatively uniform and moderately extensive granular deposits in the majority of alveoli in affected areas in a 12-month-old male GM−/− mouse; note abnormally distended alveolar macrophage (arrow). (B) Grade 4 proteinosis: uniformly confluent deposits appearing to completely fill affected alveoli in a 21-week-old female G−/−GM−/− mouse. (C) Grade 2 lymphoid accumulation: moderately large segmental lymphoid focus < 10 cells thick in a 43-week-old female G−/−GM−/− mouse. (D) Grade 4 lymphoid accumulation: extensive areas of lymphoid accumulation no longer confined to the perivascular zone, but extending interstitially into the surrounding lung parenchyma in a 29-week-old female G−/−GM−/− mouse; note confluent areas of surfactant accumulation within alveoli (grade 4 proteinosis). (All sections are stained with hematoxylin and eosin [H&E]; A and B are original magnification ×1,360, and C and D are ×340.)

Fig. 3.

Illustrative sections of the range of severity of the observed pulmonary pathology. (A) Grade 2 proteinosis: relatively uniform and moderately extensive granular deposits in the majority of alveoli in affected areas in a 12-month-old male GM−/− mouse; note abnormally distended alveolar macrophage (arrow). (B) Grade 4 proteinosis: uniformly confluent deposits appearing to completely fill affected alveoli in a 21-week-old female G−/−GM−/− mouse. (C) Grade 2 lymphoid accumulation: moderately large segmental lymphoid focus < 10 cells thick in a 43-week-old female G−/−GM−/− mouse. (D) Grade 4 lymphoid accumulation: extensive areas of lymphoid accumulation no longer confined to the perivascular zone, but extending interstitially into the surrounding lung parenchyma in a 29-week-old female G−/−GM−/− mouse; note confluent areas of surfactant accumulation within alveoli (grade 4 proteinosis). (All sections are stained with hematoxylin and eosin [H&E]; A and B are original magnification ×1,360, and C and D are ×340.)

Close modal

Given the propensity for pulmonary infection in these mice, we examined the influence of environment on the development of these lung changes. A group of eight 20-week-old male G−/−GM−/− mice raised in a conventional animal house environment were compared with six age- and sex-matched mice raised in specific pathogen–free (SPF) conditions. No discernible influence of environment was evident at this single time point analyzed in adulthood (data not shown).

Long-term survival and causes of death.Cohorts of control, G−/−, GM−/−, and G−/−GM−/− mice balanced for gender were selected after weaning, maintained in a conventional environment, and evaluated until death or until illness necessitating killing. At the time of analysis, the median age of surviving animals was 79 weeks (range, 65 to 94), and a total of 111 animals had died. No differences in survival by gender within any of the genotypes were apparent, so subsequent analyses combined genders. As expected, the median survival of wild-type mice had not been reached, and their 18-month actuarial survival rate was 84% ± 5% (Fig 4).

Fig. 4.

Impaired survival of growth factor–deficient mouse strains. Mixed-gender cohorts of wild-type (n = 60), GM−/− (n = 44), G−/− (n = 62), and G−/−GM−/− (n = 53) mice were set aside after successful weaning and studied until death or distress necessitating killing. Survival is plotted according to the method of Kaplan and Meier, and P values are based on comparisons using the log-rank test. Survival of G−/−, GM−/−, and G−/−GM−/− strains was impaired relative to wild-type mice (P < .0001). Survival of G−/−GM−/− mice was inferior to both G−/− and GM−/− animals (each P ≤ .022).

Fig. 4.

Impaired survival of growth factor–deficient mouse strains. Mixed-gender cohorts of wild-type (n = 60), GM−/− (n = 44), G−/− (n = 62), and G−/−GM−/− (n = 53) mice were set aside after successful weaning and studied until death or distress necessitating killing. Survival is plotted according to the method of Kaplan and Meier, and P values are based on comparisons using the log-rank test. Survival of G−/−, GM−/−, and G−/−GM−/− strains was impaired relative to wild-type mice (P < .0001). Survival of G−/−GM−/− mice was inferior to both G−/− and GM−/− animals (each P ≤ .022).

Close modal

The survival of G−/−, GM−/−, and G−/−GM−/− animals was significantly inferior to that of wild-type animals; median survival durations were 70, 71, and 56 weeks, respectively (Fig 4). The survival of G−/− and GM−/− mice was comparable; however, G−/−GM−/− mice had a significantly shorter survival than either GM−/− or G−/− animals. The temporal pattern of mortality also differed between genotypes. The survival of G−/− and GM−/− mice did not diverge significantly from that of control animals until 45 and 60 weeks of age, respectively, whereas the survival of G−/−GM−/− mice was significantly inferior to that of wild-type mice from 16 weeks onward.

At death, G−/−GM−/− animals were more cachectic than the other genotypes; the body weight was 25 ± 4 g for G−/−GM−/−, 31 ± 7 g for wild-type, 30 ± 7 g for G−/−, and 32 ± 7 g for GM−/− animals. The apparent cause of death and histologic findings at autopsy differed according to genotype (Table 3).

Table 3.

Analysis of Survival Cohorts of Wild-Type, G−/−, GM−/−, and G−/−GM−/− Mice

GenotypeNo. of DeathsMean Age at Death (wk)3-152Apparent Primary CauseInfections EncounteredOther Findings
(no. examined)3-150of Death (no. of mice)(% animals affected)
Wild-type 8 (4) 44 ± 20 Bowel tumor (2) None evident  
   Renal cyst (1)   
   No cause evident (1)   
G−/− 31 (24) 53 ± 16 Infection and amyloid (10) Any infection (63%) No pulmonary infections found 
   Infection alone (5) Superficial cellulitis (38%) Amyloidosis in 54% 
   No cause evident (4) Abscess formation (hepatic, intraabdominal, or perianal) (25%) Thickening of alveolar septae in 79% 
   Tumors (lymphoma, soft-tissue, pancreatic) (3) Bacterial isolates: S aureus × 1, P mirabilis × 1, Pasturella haemolytica × 1, Enterococci × 1  
   Amyloid without infection (2)   
GM−/− 29 (19) 66 ± 12 Proteinosis and lung infection (8) Any infection (84%) All animals had lung proteinosis3-151 
   Extrapulmonary infection (7) Pulmonary infection (53%) Amyloidosis in 16% 
   Lung proteinosis alone (3) Soft-tissue infections (42%)  
   Tumor (uterine) (1) Bacterial isolates: S aureus × 1, Pasturella pneumotropica × 3, Streptococcus sp. × 2  
G−/−GM−/− 43 (25) 49 ± 19 Extrapulmonary infection (8) Any infection (64%) All animals had lung proteinosis; lymphoid accumulation more severe and widespread than in GM−/− 3-151 
   Proteinosis and lung infection (7) Pulmonary infection (36%) Thickening of alveolar septae in 33% 
   Lung proteinosis alone (6) Soft-tissue infection (36%) Amyloidosis in 25% 
   No cause evident (3) Bacterial isolates: S aureus × 1  
   Tumor (lung) (1)   
GenotypeNo. of DeathsMean Age at Death (wk)3-152Apparent Primary CauseInfections EncounteredOther Findings
(no. examined)3-150of Death (no. of mice)(% animals affected)
Wild-type 8 (4) 44 ± 20 Bowel tumor (2) None evident  
   Renal cyst (1)   
   No cause evident (1)   
G−/− 31 (24) 53 ± 16 Infection and amyloid (10) Any infection (63%) No pulmonary infections found 
   Infection alone (5) Superficial cellulitis (38%) Amyloidosis in 54% 
   No cause evident (4) Abscess formation (hepatic, intraabdominal, or perianal) (25%) Thickening of alveolar septae in 79% 
   Tumors (lymphoma, soft-tissue, pancreatic) (3) Bacterial isolates: S aureus × 1, P mirabilis × 1, Pasturella haemolytica × 1, Enterococci × 1  
   Amyloid without infection (2)   
GM−/− 29 (19) 66 ± 12 Proteinosis and lung infection (8) Any infection (84%) All animals had lung proteinosis3-151 
   Extrapulmonary infection (7) Pulmonary infection (53%) Amyloidosis in 16% 
   Lung proteinosis alone (3) Soft-tissue infections (42%)  
   Tumor (uterine) (1) Bacterial isolates: S aureus × 1, Pasturella pneumotropica × 3, Streptococcus sp. × 2  
G−/−GM−/− 43 (25) 49 ± 19 Extrapulmonary infection (8) Any infection (64%) All animals had lung proteinosis; lymphoid accumulation more severe and widespread than in GM−/− 3-151 
   Proteinosis and lung infection (7) Pulmonary infection (36%) Thickening of alveolar septae in 33% 
   Lung proteinosis alone (6) Soft-tissue infection (36%) Amyloidosis in 25% 
   No cause evident (3) Bacterial isolates: S aureus × 1  
   Tumor (lung) (1)   
F3-150

Animals found dead were not subject to histologic or microbiologic analysis.

F3-151

Both the mean severity and extent of lymphoid perivascular accumulation were greater in G−/−GM−/− mice than in GM−/− mice (3.0 v 2.1 and 79% v 44%, respectively, both P ≤ .0004), whereas the mean severity and extent of surfactant accumulation were not significantly different in G−/−GM−/− and GM−/− animals at the time of death (2.7 v 2.7 and 73% v 83%, respectively, both P > .1).

F3-152

Mean age ± 1 SD of all animals dying, regardless of whether found dead or killed.

G−/−.At death, 63% of G−/− mice had microbiologic or histologic evidence of infection. The cellular infiltrate at sites of infection was composed predominantly of lymphocytes and macrophages, with scattered plasma cells (Fig 5A). Despite peripheral blood neutrophil counts as high as 1.12 × 109/L, neutrophils were infrequent at sites of infection compared with the cellular infiltrate seen in GM−/− animals (Fig 5B). None of 24 G−/− animals had histologic evidence of pulmonary infection, although in 79% of the animals there were foci of alveolar septal hypercellularity with hyperplasia of cuboidal type II alveolar cells in the absence of inflammatory infiltrate (Fig 5D). These changes were not related to the presence of infection at other sites, amyloid deposition either within the lungs or elsewhere, or gender, and no such abnormalities were seen in the lungs of six apparently healthy G−/− mice aged 6 to 7 months.

Fig. 5.

Variable cellular composition of inflammatory infiltrates and novel aspects of pulmonary pathology in growth factor–deficient mice. (A) Cellular inflammatory infiltrate surrounding an intraabdominal abscess in a 73-week-old female G−/− mouse illustrating the scarcity of neutrophils (circled) and the predominance of lymphocytes (solid arrow) and macrophages (hollow arrow). Cultures from this abscess grew both Proteus mirabilis and Enterococcus species. (B) Representative view of the cellular inflammatory infiltrate within a bronchiole in an area of pneumonia in a 71-week-old GM−/− mouse illustrating the predominance of morphologically normal neutrophils. (C) Cellular inflammatory infiltrate surrounding a pulmonary abscess in a 37-week-old female G−/−GM−/− mouse illustrating the scarcity of neutrophils, with the majority of cells being lymphocytes (solid arrow) and macrophages (hollow arrow). (D) Representative field of lung abnormality in a 45-week-old female G−/− animal showing marked hypercellularity of alveolar septae in the absence of pulmonary infection (compare with appearance of normal alveolar septae in GM−/− mice in Fig 3A). (E) Similar appearance of alveolar septae in a 64-week-old male G−/−GM−/− mouse with relatively minor surfactant accumulation (arrows). (All sections are stained with H & E; C is original magnification ×2,040, and all others are ×1,360.)

Fig. 5.

Variable cellular composition of inflammatory infiltrates and novel aspects of pulmonary pathology in growth factor–deficient mice. (A) Cellular inflammatory infiltrate surrounding an intraabdominal abscess in a 73-week-old female G−/− mouse illustrating the scarcity of neutrophils (circled) and the predominance of lymphocytes (solid arrow) and macrophages (hollow arrow). Cultures from this abscess grew both Proteus mirabilis and Enterococcus species. (B) Representative view of the cellular inflammatory infiltrate within a bronchiole in an area of pneumonia in a 71-week-old GM−/− mouse illustrating the predominance of morphologically normal neutrophils. (C) Cellular inflammatory infiltrate surrounding a pulmonary abscess in a 37-week-old female G−/−GM−/− mouse illustrating the scarcity of neutrophils, with the majority of cells being lymphocytes (solid arrow) and macrophages (hollow arrow). (D) Representative field of lung abnormality in a 45-week-old female G−/− animal showing marked hypercellularity of alveolar septae in the absence of pulmonary infection (compare with appearance of normal alveolar septae in GM−/− mice in Fig 3A). (E) Similar appearance of alveolar septae in a 64-week-old male G−/−GM−/− mouse with relatively minor surfactant accumulation (arrows). (All sections are stained with H & E; C is original magnification ×2,040, and all others are ×1,360.)

Close modal

GM−/−.All mice examined had typical features of the previously reported lung pathology.6 7 The alveolar septae were uniformly normal (Fig 3A). Microbiologic or histologic evidence of infection was present in 84% of the animals, and involved the lung as lobar or bronchial pneumonia or pulmonary abscess formation in 53% of the mice. Inflammatory cellular infiltrates at the sites of infection contained predominantly neutrophils, with few lymphocytes, macrophages, and plasma cells (Fig 5B). The peripheral blood neutrophil count was significantly elevated in six infected mice analyzed (mean, 4.51 × 109/L).

G−/−GM−/−.The histologic findings in G−/−GM−/− animals combined features of both constituent genotypes, but with more severe and widespread pulmonary perivascular lymphoid accumulation (Table 3). One third of the animals showed focal areas of hypercellularity of the alveolar septae (Fig 5E), as noted in G−/− mice. Microbiologic or histologic evidence of infection was present in 64% of the mice, and involved the lungs in 36% of the animals. As in G−/− mice, morphologically recognizable neutrophils were infrequent at sites of infection (Fig 5C), despite peripheral blood neutrophil counts as high as 1.54 × 109/L (mean, 0.56 × 109/L; n = 6). The only organism cultured from these sites was Staphylococcus aureus, although Gram-negative bacilli were seen within lung abscesses.

Nature and manifestation of amyloidosis.In the initial histologic survey of 8- to 12-week-old G−/−GM−/− mice, a single animal was found to have moderate splenomegaly and hepatomegaly due to deposition of acellular eosinophilic material. Congo red staining confirmed this to be amyloid, prompting a more complete survey among animals individually lacking G-CSF or GM-CSF. Although not previously noted,5 G-CSF–deficient animals were also found to have a high incidence of amyloid.

The gross and histologic manifestations of amyloidosis were similar in affected animals of all genotypes studied. Amyloidotic animals had a pale and enlarged spleen (242 ± 133 and 173 ± 91 mg for animals with and without histologic evidence of amyloid, respectively, P = .034). The frequency and severity of organ involvement was surveyed by microscopic examination of sections from the heart, lungs, bowel, spleen, liver, and kidneys of 50 affected mice (Table 4). The most commonly and severely involved organs were the liver and spleen, with no differences in the pattern of organ involvement evident between genotypes.

Table 4.

Manifestations of Amyloidosis

GenotypeIncidence ofNo. of AffectedPercentage of Organs Positive in Affected Animals (mean severity score*)
Amyloid (%)Mice ExaminedLiverSpleenKidneyBowelHeartLung
Wild-type 0 (0) 0 (0) 100 (1.0) 0 (0) 0 (0) 100 (1.0) 
GM−/− 10 100 (1.5) 100 (1.3) 50 (0.5) 50 (0.8) 75 (0.8) 50 (0.5) 
G−/− 46 22 86 (1.3) 86 (1.8) 67 (1.1) 73 (1.1) 73 (0.8) 36 (0.4) 
G−/−GM−/− 32 23 91 (1.3) 91 (1.6) 64 (0.7) 71 (1.1) 48 (0.5) 57 (0.6) 
Total 27 50 88 (1.3) 88 (1.6) 65 (0.9) 69 (1.0) 60 (0.6) 48 (0.5) 
GenotypeIncidence ofNo. of AffectedPercentage of Organs Positive in Affected Animals (mean severity score*)
Amyloid (%)Mice ExaminedLiverSpleenKidneyBowelHeartLung
Wild-type 0 (0) 0 (0) 100 (1.0) 0 (0) 0 (0) 100 (1.0) 
GM−/− 10 100 (1.5) 100 (1.3) 50 (0.5) 50 (0.8) 75 (0.8) 50 (0.5) 
G−/− 46 22 86 (1.3) 86 (1.8) 67 (1.1) 73 (1.1) 73 (0.8) 36 (0.4) 
G−/−GM−/− 32 23 91 (1.3) 91 (1.6) 64 (0.7) 71 (1.1) 48 (0.5) 57 (0.6) 
Total 27 50 88 (1.3) 88 (1.6) 65 (0.9) 69 (1.0) 60 (0.6) 48 (0.5) 

There were no statistically significant differences evident in either the distribution or severity of amyloidosis between genotypes.

F4-150

Severity of amyloid deposition was scored using the criteria of Janigan,14 where 1 = slight, 2 = moderate, and 3 = extensive, as originally defined.

In mild to moderate cases (grade 1 to 2), splenic amyloid deposits were predominantly perifollicular with preservation of the white pulp (Fig 6A). However, in more severe cases (grade 3), the residual lymphoid follicles were atrophic (Fig 6B) and subcapsular hematopoiesis was absent. In the liver, amyloid was deposited predominantly surrounding central veins (Fig 6C) and at portal triads, but in severe cases it radiated into the hepatic lobules between plates of hepatocytes. There was no associated inflammatory infiltrate or hepatocyte necrosis. In the bowel, amyloid deposits were limited to the submucosa (Fig 6D), and in the kidney, they were most evident in the glomerular vasculature (Fig 6E) and papillae. In other organs, deposition was limited to the wall and perivascular tissues of small- to medium-sized blood vessels. Pulmonary amyloid deposits were always clearly separate and distinct from any coincident surfactant accumulation.

Fig. 6.

Range of manifestations of amyloidosis in growth factor–deficient mice. (A) Moderate (grade 2) splenic amyloid in an infected 50-week-old female G−/− mouse demonstrating the usual pattern of perifollicular localization of homogeneous acellular eosinophilic material with relative preservation of the splenic white pulp (original magnification ×340, H & E). (B) Extensive (grade 3) confluent splenic amyloid deposits in a 67-week-old female G−/−GM−/− animal with residual atrophic lymphoid follicles (arrows). The mouse was culled due to the presence of a soft-tissue abscess that grew S aureus (original magnification ×340, H & E). (C) Congo red positively stained hepatic amyloid deposition around the central vein in an 81-week-old female G−/−GM−/− mouse (original magnification ×1,360, Congo red). (D) Intestinal amyloid within the submucosa of villi showing characteristic green birefringence when viewed under crossed polarizing filters (same animal as C); original magnification ×1,360, Congo red). (E) Renal amyloid resulting in obliteration of the normal glomerular vasculature in a 48-week-old male G−/−GM−/− mouse (original magnification ×1,360, H & E).

Fig. 6.

Range of manifestations of amyloidosis in growth factor–deficient mice. (A) Moderate (grade 2) splenic amyloid in an infected 50-week-old female G−/− mouse demonstrating the usual pattern of perifollicular localization of homogeneous acellular eosinophilic material with relative preservation of the splenic white pulp (original magnification ×340, H & E). (B) Extensive (grade 3) confluent splenic amyloid deposits in a 67-week-old female G−/−GM−/− animal with residual atrophic lymphoid follicles (arrows). The mouse was culled due to the presence of a soft-tissue abscess that grew S aureus (original magnification ×340, H & E). (C) Congo red positively stained hepatic amyloid deposition around the central vein in an 81-week-old female G−/−GM−/− mouse (original magnification ×1,360, Congo red). (D) Intestinal amyloid within the submucosa of villi showing characteristic green birefringence when viewed under crossed polarizing filters (same animal as C); original magnification ×1,360, Congo red). (E) Renal amyloid resulting in obliteration of the normal glomerular vasculature in a 48-week-old male G−/−GM−/− mouse (original magnification ×1,360, H & E).

Close modal

The amyloid deposits were the serum amyloid A (AA), or reactive type, since Congo red staining was abolished by pretreatment with potassium permanganate in two representative cases of affected G−/− and G−/−GM−/− mice (data not shown).

Factors associated with the presence of amyloidosis.A total of 186 animals were examined for the presence of amyloidosis (26 control, 48 G−/−, 40 GM−/−, and 72 G−/−GM−/−). Of these, 123 were culled for illness, and 63 were apparently healthy and killed specifically for study. Amyloid was seen most frequently among G−/− and G−/−GM−/− mice (Table 4), although such an analysis is confounded by variation in other potentially significant risk factors between genotypes.

To more accurately assess the specific characteristics associated with the development of amyloidosis, a forward stepwise multivariate regression analysis was performed (Table 5) incorporating the following potentially contributory factors: G-CSF genotype (+/+ v −/−), GM-CSF genotype (+/+ v −/−), status at analysis (culled for illness v killed healthy), gender, presence of infection, environment (all as discrete variables), and age (as a continuous variable). Overall, nullizygosity for G-CSF, male gender, and culling due to illness were independently associated with the presence of amyloidosis. The lack of GM-CSF had no influence on the risk of developing amyloid.

Table 5.

Multivariate Analysis of Risk Factors for Amyloidosis

VariableMultivariate P
Whole cohort (N = 186)5-150 
Lack of G-CSF .00007 
Male gender .0012 
Animals culled for illness .0056 
Uninfected animals (n = 101)5-151 
Lack of G-CSF .0086 
Male gender .0031 
VariableMultivariate P
Whole cohort (N = 186)5-150 
Lack of G-CSF .00007 
Male gender .0012 
Animals culled for illness .0056 
Uninfected animals (n = 101)5-151 
Lack of G-CSF .0086 
Male gender .0031 
F5-150

GM-CSF genotype (+/+ v −/−), age (as a continuous variable), environment (standard animal house v SPF), and the presence of infection were examined as independent variables and did not enter the final multivariate model.

F5-151

GM-CSF genotype (+/+ v −/−), age (as a continuous variable), status at analysis (culled for illness v killed healthy for study), and environment (standard animal house v SPF) were examined as independent variables and did not enter the final multivariate model.

Given the association of chronic infection with amyloidosis17 18 and the predisposition of growth factor–deficient strains to infection, 101 animals without gross, histologic, or microbiologic evidence of infection were analyzed separately (22 wild-type, 22 G−/−, 22 GM−/−, and 35 G−/−GM−/−; Table 5). Among these “uninfected” animals, a lack of G-CSF and male gender were predictive of amyloidosis. Status at analysis was no longer significant, possibly due to its strong correlation with the presence of infection. It is notable that the SPF environment did not measurably reduce the incidence of amyloidosis. Of 22 SPF-raised animals examined (all apparently healthy males with a mean age of 10 months: four control, four G−/−, four GM−/−, and 10 G−/−GM−/−), six had evidence of amyloid (two G−/− and four G−/−GM−/−).

Despite numerous in vitro studies documenting the biologic capacity of hematopoietic colony-stimulating factors, their physiologic roles in vivo remain incompletely defined. The existence of spontaneous null mutants19 and the generation of gene-targeted mice lacking either factors5-7,20 or their receptors21-26 have provided important insights into the unique functions of these cytokines and their signal transduction pathways. G-CSF and GM-CSF have significant granulopoietic activity in vitro, many aspects of which are common to both factors. However, mice deficient in each of these factors have characteristic but dissimilar features, establishing the existence of unique functional roles for G-CSF and GM-CSF in vivo.5-7 We generated mice lacking both G-CSF and GM-CSF to further explore the possibility of shared in vivo functions.

Although normal lung fibroblasts can be induced to produce G-CSF in vitro,27 the lungs do not constitutively produce this factor in vivo.28 Together with the reported lack of pulmonary abnormalities in mice lacking either G-CSF5 or the G-CSF receptor,26 this demonstrates that G-CSF does not play a critical role in lung homeostasis in the unperturbed state. However, the high rate of focal histologic abnormalities of the alveolar septae among animals of both strains lacking G-CSF (G−/−GM+/+ and G−/−GM−/−) killed due to illness suggests that G-CSF may have an important indirect role in pulmonary function under some circumstances. The abundance of type II pneumocytes noted in mice lacking G-CSF resembles the changes described in the syndrome of “diffuse alveolar damage,”29 the features of which can be produced experimentally by intratracheal administration of lipopolysaccharide30 or overexpression of tumor necrosis factor-α.31 The absence of such abnormalities in infected and moribund GM−/− mice suggests that a component of the host response influenced by G-CSF rather than an underlying infection itself is critical in the pathogenesis of these pulmonary changes.

Lung abnormalities attributable to the deficiency of GM-CSF were not exacerbated by the additional lack of G-CSF. This is similar to findings in mice lacking either functional receptors for interleukin-5 (IL-5)21,22 or both IL-3 and functional IL-5 receptors25 in addition to GM-CSF, where there was no detectable exacerbation of the lung disease attributable to the loss of the actions of GM-CSF alone.21,22 25 

The degree of steady-state neutropenia in adult G−/−GM−/− mice was no more severe than in animals lacking G-CSF alone, demonstrating that GM-CSF is not essential for the residual granulopoiesis observed in adult G−/− mice. Further, in contrast to op/op mice, which lack active M-CSF,32 33 G−/− and G−/−GM−/− mice show no evidence of hematopoietic recovery up to 18 months of age. The age-dependent correction of some of the hematopoietic defects associated with op/op mice illustrates the potential plasticity of the hematopoietic system and its capacity to use alternative compensatory mechanisms, presumably in the form of growth factors with partially overlapping functions. The lack of any age-related correction of the phenotypes of any of the three factor-deficient strains in the current analysis indicates that the phenomenon of age-dependent amelioration in factor-deficient animals is probably exceptional.

The greater degree of neutropenia up to 2 weeks of age in G−/−GM−/− animals compared with singly G-CSF–deficient mice establishes that under certain circumstances GM-CSF can contribute to steady-state neutrophil production in vivo, even though GM−/− mice are not neutropenic at any time point. The failure to demonstrate any such worsening of neutropenia in adult G−/−GM−/− mice is consistent with the notion that the contribution of factors regulating hematopoiesis may vary during different developmental periods. This notion is also supported by the finding that young G-CSF–deficient mice are proportionally less neutropenic than adult animals of the same genotype.

The factors controlling the patterned changes in hepatic, splenic, and medullary hematopoiesis through the fetal and neonatal periods are unknown.34 Since all strains examined manifest the normal dynamic alterations in neutrophil levels during the first 8 weeks of life, neither G-CSF nor GM-CSF appears essential for these changes, although available data had suggested that their involvement was possible.35-41 Murine fetal tissues do not produce significant quantities of G-CSF or GM-CSF,35 but maternal G-CSF can cross the placenta and remain biologically active.36 Also, both of these factors,35,37-40 as well as M-CSF,35 41 are produced locally within the placenta and pregnant uterus and may potentially act systemically to influence hematopoiesis during the fetal and early neonatal periods.

In mice lacking both G-CSF and GM-CSF, the reduction in both marrow and splenic progenitor numbers and the percentage of bone marrow myeloid precursors were no greater than in G-CSF–deficient mice. Previous reports and the current analysis describe increased numbers of splenic progenitors in GM−/− mice,6 but a reduction in G−/− mice.5 It is therefore noteworthy that the number of splenic progenitors in G−/−GM−/− mice was significantly lower than in wild-type mice but indistinguishable from that in G-CSF–deficient animals, demonstrating that G-CSF is necessary for, and may be responsible for, the enhanced splenic hematopoiesis in GM−/− mice.

The initial report of GM-CSF–deficient mice found no impairment of reproductive capacity based on the study of five litters,6 and no data have been published on the fertility of mice lacking the GM-CSF receptor β-common chain.21,22,25 The current analysis demonstrates a modest reduction in the litter size of GM−/− animals. This suggests an indispensable physiologic role for GM-CSF in optimizing reproductive function, and is consistent with the observation that administration of a GM-CSF–neutralizing antibody to pregnant mice results in an increased rate of spontaneous abortion.42 The expression and secretion of GM-CSF by placental tissue35,38,40 and the responsiveness of both trophoblast43 and nontrophoblast placental cells to GM-CSF44 suggest that GM-CSF has a role in placental formation or function. This is supported by the capacity of injected GM-CSF to increase both placental and fetal weight and enhance fertility in CBA × DBA/2 mice, which have a high background rate of spontaneous abortion.42,45 A possible explanation for these observations is suggested by the finding that in vitro the perfused ovaries of GM−/− mice have a blunted progesterone response to gonadotropin stimulation.46 Additionally, if the breeding data suggesting a selective loss of doubly nullizygous embryos among the progeny of double heterozygote crosses are confirmed, this would be consistent with a specific role for embryo-derived GM-CSF in these processes. However, the methods used cannot definitively establish the contribution of prenatal versus postnatal events, and such a role remains speculative.

Mice lacking either GM-CSF or G-CSF individually had significantly impaired long-term survival. In GM-CSF–deficient mice, this was attributable to both pulmonary and soft-tissue infections and “alveolar proteinosis-like” lung disease. The finding of a significant peripheral blood neutrophilia in a number of GM−/− mice with sporadic infections and the prominent neutrophilic infiltration at sites of infection suggest that GM-CSF is not required for augmented granulopoiesis or neutrophil localization in response to some stimuli.25 47 However, the increased incidence of soft-tissue infections observed in GM-CSF–deficient animals despite apparently adequate peripheral blood neutrophilia and neutrophil localization suggests a possible impairment in some aspect of microbial killing.

G-CSF–deficient mice had similarly increased mortality, predominantly due to severe infections. Surprisingly, there were no pulmonary infections seen despite prolonged neutropenia, consistent with the primary role of the alveolar macrophage in the prevention of pulmonary infection. In G−/− animals, neutrophils were infrequent at sites of infection, possibly due to the steady-state peripheral blood neutropenia and impaired granulopoietic response to microbial challenge5 or a defect in neutrophil localization. However, no such localization defect was detected in response to either intraperitoneal casein47 or thioglycollate.26 

Many of the pathologic features of the doubly deficient G−/−GM−/− mice are consistent with the additive effects of the constituent genotypes. Thus, these animals manifest a high rate of soft-tissue and pulmonary infections, together with alveolar proteinosis-like lung disease, hypercellularity of the alveolar septae, and a mortality rate significantly greater than either of the singly deficient strains. In G−/−GM−/− animals, as in those lacking G-CSF alone, neutrophils were infrequent at sites of infection.

Finally, mice of both strains lacking G-CSF had a greatly increased propensity to develop reactive AA-type amyloidosis, with the dominant role of G-CSF, independent of GM-CSF genotype and the associated predisposition to infection, confirmed in multivariate analyses. There is a low background incidence of spontaneous AA-type amyloidosis in many mouse strains, with a higher rate beyond 12 months of age, particularly among fighting males and in the presence of infection.17,18 48 We found a 4% incidence of amyloidosis among wild-type mice, whereas 10% of GM−/− mice, many of which had evidence of infection, were affected. Although male gender and the need for animals to be culled due to illness were also independently associated with the incidence of amyloid, the absence of G-CSF, and the resulting chronic neutropenia, was the most significant predictor identified.

Other animal models have previously implicated chronic neutropenia in the pathogenesis of amyloidosis. Gray collie dogs with cyclic neutropenia develop AA-type amyloidosis,49,50 as do the progeny of hybrid mice selected and interbred on the basis of leukopenia.51 52 While not dismissing the contribution of underlying infection, these models suggest that neutropenia per se may predispose to the development of AA-type amyloidosis.

The major constituent of tissue deposits in AA-type amyloidosis is a cleavage product of serum amyloid-A protein, which is synthesized by the liver as an acute-phase protein under the control of IL-1α, IL-6,53-56 and possibly other gp 130-linked cytokines.57 One hypothesis that may explain the link between neutropenia and amyloidosis is the counterregulatory increase in the activity of one or more of the factors regulating serum amyloid-A in response to chronic neutropenia. Teleologically, such a response could be explained by the capacity of one or more of these cytokines to enhance granulopoiesis.58 Studies to investigate this hypothesis are ongoing, and the susceptibility of mice deficient in both G-CSF and IL-6 to amyloidosis will be useful in addressing this issue.

The authors thank Dr E. Stanley for his role in the generation of the GM−/− mice used in this study, Dr V. Sinickas for microbiologic analyses, Dr A. Grigg for access to the Sysmex automated analyzer, the animal house staff for animal husbandry, V. Feakes for preparation of histologic sections and special stains, Dr I. Gordon for statistical guidance, and Prof A. Burgess for his critical reading of the manuscript.

Supported in part by a National Health and Medical Research Council Medical Postgraduate Research Scholarship (J.F.S.).

Address reprint requests to John F. Seymour, MB, BS, Ludwig Institute for Cancer Research, Melbourne Tumour Biology Branch, PO Box 2008 Royal Melbourne Hospital, Victoria, 3050 Australia.

1
Metcalf D, Nicola NA: The Hematopoietic Colony Stimulating Factors. Cambridge, MA, Cambridge University Press, 1995
2
Lieschke
GJ
Burgess
AW
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. I.
N Engl J Med
327
1992
28
3
Lieschke
GJ
Burgess
AW
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. II.
N Engl J Med
327
1992
99
4
Metcalf
D
Hematopoietic regulators: Redundancy or subtlety?
Blood
82
1993
3515
5
Lieschke
GJ
Grail
D
Hodgson
G
Metcalf
D
Stanley
E
Cheers
C
Fowler
KJ
Basu
S
Zhan
YF
Dunn
AR
Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization.
Blood
84
1994
1737
6
Stanley
E
Lieschke
GJ
Grail
D
Metcalf
D
Hodgson
G
Gall
JAM
Maher
DW
Cebon
J
Sinickas
V
Dunn
AR
Granulocyte/macrophage colony-stimulating factor–deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.
Proc Natl Acad Sci USA
91
1994
5592
7
Dranoff
G
Crawford
AD
Sadelain
M
Ream
B
Rashid
A
Bronson
RT
Dickerson
GR
Bachurski
CJ
Mark
EL
Whitsett
JA
Mulligan
RC
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.
Science
264
1994
713
8
Ikegami M, Ueda T, Hull W, Whitsett JA, Mulligan RC, Dranoff G, Jobe AH: Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol 270:L650, 1996
9
Thomas
JH
Thinking about genetic redundancy.
Trends Genet
9
1993
395
10
Rugh
R
Somogyi
C
Pre- and post-natal normal mouse blood cell counts.
Proc Soc Exp Biol Med
127
1968
1267
11
Metcalf D: The Hemopoietic Colony-Stimulating Factors. Amsterdam, The Netherlands, Elsevier, 1984
12
Puchtler
H
Sweat
F
Levine
M
On the binding of Congo red by amyloid.
J Histochem Cytochem
10
1962
355
13
Wright
JR
Calkins
E
Humphrey
RL
Potassium permanganate reaction in amyloidosis: A histologic method to assist in differentiating forms of this disease.
Lab Invest
36
1977
274
14
Janigan
DT
Experimental amyloidosis: Studies with a modified casein method, casein hydrolysate and gelatin.
Am J Pathol
47
1965
159
15
Isenberg HD, Washington JA, Doern GV, Amsterdam D: Specimen collection and handling, in Balow A, Hausler WJ, Hermann KL, Isenberg HD, Shadomy HJ (eds): Manual of Clinical Microbiology (ed 5). Washington, DC, American Society for Microbiology, 1991, p 15
16
Holm
S
A simple sequentially rejective multiple test procedure.
Scand J Stat
6
1979
65
17
Glenner
GG
Page
DL
Amyloid, amyloidosis, and amyloidogenesis.
Int Rev Exp Pathol
15
1976
1
18
Page
DL
Glenner
GG
Social interaction and wounding in the genesis of “spontaneous” murine amyloidosis.
Am J Pathol
67
1972
555
19
Yoshida
H
Hayashi
S-I
Kunisada
T
Ogawa
M
Nishikawa
S
Okamura
H
Sudo
T
Shultz
LD
Nishikawa
S-I
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.
Nature
345
1990
442
20
Kopf
M
Brombacher
F
Hodgkin
PD
Ramsay
AJ
Milbourne
EA
Dai
WJ
Ovington
KS
Behm
CA
Köhler
G
Young
IG
Matthaei
KI
IL-5–deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.
Immunity
4
1996
15
21
Robb
L
Drinkwater
C
Metcalf
D
Li
R
Köntgen
F
Nicola
N
Begley
C
Hematopoietic and lung abnormalities in mice with a null mutation of the common β subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5.
Proc Natl Acad Sci USA
92
1995
9565
22
Nishinakamura
R
Nakayama
N
Hirabayashi
Y
Inoue
T
Aud
D
McNeil
T
Azuma
S
Yoshida
S
Toyoda
Y
Arai
K-I
Miyajima
A
Murray
R
Mice deficient for the IL-3/GM-CSF/IL-5 βc receptor exhibit lung pathology and impaired immune response, while βIL3 receptor–deficient mice are normal.
Immunity
2
1995
211
23
Nicola
NA
Robb
L
Metcalf
D
Cary
D
Drinkwater
CC
Begley
CG
Functional inactivation in mice of the gene for the interleukin-3 (IL-3)–specific receptor β-chain: Implications for the IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells.
Blood
87
1996
2665
24
Yoshida
T
Ikuta
K
Sugaya
H
Maki
K
Takagi
M
Kanazawa
H
Sunaga
S
Kinashi
T
Yoshimura
K
Miyazaki
J-I
Takaki
S
Takatsu
K
Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5Rα–deficient mice.
Immunity
4
1996
483
25
Nishinakamura
R
Miyajima
A
Mee
PJ
Tybulewicz
VLJ
Murray
R
Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions.
Blood
88
1996
2458
26
Liu
F
Wu
HY
Wesselschmidt
R
Kornaga
T
Link
DC
Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor–deficient mice.
Immunity
5
1996
491
27
Koeffler
HP
Gasson
J
Ranyard
J
Souza
L
Shepard
M
Munker
R
Recombinant human TNFα stimulates production of granulocyte colony-stimulating factor.
Blood
70
1987
55
28
Troutt
AB
Lee
F
Tissue distribution of murine hemopoietic growth factor mRNA production.
J Cell Physiol
138
1989
38
29
Guinee
D Jr
Fleming
M
Hayashi
T
Woodward
M
Zhang
J
Walls
J
Koss
M
Ferrans
V
Travis
W
Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage.
Am J Pathol
149
1996
531
30
Sugahara
K
Iyama
K
Sano
K
Kuroki
Y
Akino
T
Matsumoto
M
Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharide-induced injury.
Lab Invest
74
1996
209
31
Miyazaki
Y
Araki
K
Vesin
C
Garcia
I
Kapanaci
Y
Whitsett
JA
Piguet
P-F
Vassalli
P
Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis.
J Clin Invest
96
1995
250
32
Begg
SK
Radley
JM
Pollard
JW
Chisholm
OT
Stanley
ER
Bertoncello
I
Delayed hematopoietic development in osteopetrotic (op/op) mice.
J Exp Med
177
1993
237
33
Nilsson
SK
Lieschke
GJ
Garcia-Wijnen
CC
Williams
B
Tzelepis
D
Hodgson
G
Grail
D
Dunn
AR
Bertoncello
I
Granulocyte-macrophage colony-stimulating factor is not responsible for the correction of hematopoietic deficiencies in the maturing op/op mouse.
Blood
86
1995
66
34
Metcalf D, Moore MAS: Embryonic aspects of haemopoiesis, in Neuberger A, Tatum EL (eds): Frontiers of Biology, vol 24: Haemopoietic Cells. Amsterdam, The Netherlands, North-Holland, 1971, p 172
35
Metcalf
D
Wilson
TA
Hilton
DJ
Di Rago
L
Mifsud
S
Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: Measurement by specific bioassays.
Leukemia
9
1995
1556
36
Medlock
ES
Kaplan
DL
Cecchini
M
Ulich
TR
del Castillo
J
Andresen
J
Granulocyte colony-stimulating factor crosses the placenta and stimulates fetal rat granulopoiesis.
Blood
81
1993
916
37
Saito
S
Fukunaga
R
Ichijo
M
Nagata
S
Expression of granulocyte colony-stimulating factor and its receptor at the fetomaternal interface in murine and human pregnancy.
Growth Factors
10
1994
135
38
Robertson
SA
Seamark
RF
Granulocyte-macrophage colony stimulating factor (GM-CSF): One of a family of epithelial cell–derived cytokines in the preimplantation uterus.
Reprod Fertil Dev
4
1992
435
39
Shorter
SC
Vince
GS
Starkey
PM
Production of granulocyte colony-stimulating factor at the materno-foetal interface in human pregnancy.
Immunology
75
1992
468
40
Kanzaki
H
Crainie
M
Lin
H
Yui
J
Guilbert
LJ
Mori
T
Wegmann
TG
The in situ expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) mRNA at the maternal-fetal interface.
Growth Factors
5
1991
69
41
Bartocci
A
Pollard
JW
Stanley
ER
Regulation of colony-stimulating factor 1 during pregnancy.
J Exp Med
164
1986
956
42
Clark
DA
Chaouat
G
Mogil
R
Wegman
TG
Prevention of spontaneous abortion in DBA/2-mated CBA/J mice by GM-CSF involves CD8+ T cell–dependent suppression of natural effector cell cytotoxicity against trophoblast target cells.
Cell Immunol
154
1994
143
43
Drake
BL
Head
JR
GM-CSF and CSF-1 stimulate DNA synthesis but not cell proliferation in short-term cultures of mid-gestational murine trophoblast.
J Reprod Immunol
26
1994
41
44
Athanassakis
I
Bleackley
RC
Paetkau
V
Guilbert
L
Barr
PJ
Wegmann
TG
The immunostimulatory effect of T cells and T cell lymphokines on murine fetally derived placental cells.
J Immunol
138
1987
37
45
Chaouat
G
Menu
E
Clark
DA
Dy
M
Minkowski
M
Wegmann
TG
Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy.
J Reprod Fertil
89
1990
447
46
Jasper MJ, McKie KH, Robertson SA, Norman RJ: In vitro perfusion of ovaries from GM-CSF deficient mice. Proc Endocr Soc Aust 39:99, 1996 (abstr 120)
47
Metcalf
D
Robb
L
Dunn
AR
Mifsud
S
Di Rago
L
Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice.
Blood
88
1996
3755
48
Majeed
SK
Survey on spontaneous systemic amyloidosis in aging mice.
Arzneimittelforschung
43
1993
170
49
Cheville
NF
Amyloidosis associated with cyclic neutropenia in the dog.
Blood
31
1968
111
50
Machado
EA
Gregory
RS
Jones
JB
Lange
RD
The cyclic hematopoietic dog: A model for spontaneous secondary amyloidosis. A morphologic study.
Am J Pathol
92
1978
23
51
Chai
CK
Genes associated with leukocyte production in mice.
J Hered
66
1975
301
52
Bannerman RM: Hematology, in Foster HL, Small JD, Fox JG (eds): The Mouse in Biomedical Research, vol 3: Normative Biology, Immunology, and Husbandry. New York, NY, Academic, 1983, p 294
53
Gruys
E
Snel
FWJJ
Animal models for reactive amyloidosis.
Baillieres Clin Rheumatol
8
1994
599
54
Ganapathi
MK
Rzewnicki
D
Samols
D
Jiang
S-L
Kushner
I
Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells.
J Immunol
147
1991
1261
55
Gabay
C
Genin
B
Mentha
G
Iynedjian
PB
Roux-Lombard
P
Guerne
P-A
IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells.
Clin Exp Immunol
100
1995
306
56
Rygg
M
Cytokine-induced differential expression of serum amyloid A genes in fetal and neonatal rabbits.
Clin Exp Immunol
103
1996
335
57
Benigni
F
Fantuzzi
G
Sacco
S
Sironi
S
Pozzi
P
Dinarello
CA
Sipe
JD
Poli
V
Cappelletti
M
Paonessa
G
Pennica
D
Panayotatos
N
Ghezzi
P
Six different cytokines that share GP130 as a receptor subunit induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamic-pituitary-adrenal axis by interleukin-1.
Blood
87
1996
1851
58
Metcalf
D
The granulocyte-macrophage regulators: Reappraisal by gene inactivation.
Exp Hematol
23
1995
569
Sign in via your Institution